InnovivavsEli Lilly and Company

INVA and LLY stock compared: price, dividend, valuation and results, from SEC filings.

LLY

Eli Lilly and Company

$1,395.24

Value $1.32T

-1.33%
LLY's page

Innoviva (INVA) has a market value of $1.4B and Eli Lilly and Company (LLY) $1.32T. Over the last year, with dividends, INVA moved -16.4% and LLY +37.4%. The P/E is 7.0 for INVA and 47.7 for LLY. Dividend yield: INVA none, LLY 0.45%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    INVA$1.4B

    LLY$1.32T

    LLY is 968 times INVA

  • Revenue, 12 months

    INVA$438M

    LLY$86.5B

    LLY is 197 times INVA

  • Net income, 12 months

    INVA$193M

    LLY$27.6B

    LLY is 143 times INVA

  • Operating margin

    INVA38.8%

    LLY–

  • ROIC

    INVA9.5%

    LLY35.5%

    26.0 points apart

  • P/E

    INVA7.0

    LLY47.7

    LLY is 6.8 times INVA

  • Dividend yield

    INVA0.0%

    LLY0.4%

    0.5 points apart

  • 5-year return

    INVA+6.4%

    LLY+457.8%

    451.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

INVA+6.4%

LLY+457.8%

20040060020222023202420252026
Returns by period
PeriodINVAWith dividendsLLYWith dividends
1 year since November 17, 2025-16.4%Price -16.4%+37.4%Price +36.6%
3 years since November 17, 2023+33.8%+10.2% a yearPrice +33.8%+140.5%+34.0% a yearPrice +135.8%
5 years since November 17, 2021+6.4%+1.3% a yearPrice +6.4%+457.8%+41.0% a yearPrice +434.2%
10 years since November 18, 2016+68.3%+5.3% a yearPrice +68.3%+2,016.8%+35.7% a yearPrice +1,719.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

INVAInnovivaLLYEli Lilly and Company

Valuation

INVALLY
Valuation
Price$18.36$1,395.24
Market value$1.4B$1.32T
Enterprise value (EV)$1.0B$1.36T
P/E7.047.7
P/E, 5-year median6.149.9
P/B1.232.7
EV/EBIT6.139.1
Free cash flow yield13.4%1.5%

Results and growth

INVALLY
Results and growth
Revenue, 12 months$438M$86.5B
Net income, 12 months$193M$27.6B
Free cash flow, 12 months$183M$19.7B
Earnings per share, 12 months$2.61$30.81
Revenue growth, year on year14.7%44.7%
Revenue growth a year, past+4.1%over 5 years+21.6%over 5 years
EPS growth a year, past+10.3%over 5 years+27.6%over 5 years

Margins and returns on capital

INVALLY
Margins and returns on capital
Gross margin74.5%83.6%
Operating margin38.8%–
Net margin44.1%31.9%
ROIC9.5%35.5%
ROE16.4%88.6%

Balance sheet

INVALLY
Balance sheet
Cash$581M$4.9B
Total debt$270M$49.5B
Net debt / EBITDA–1.2
Interest cover8.6×38.9×

Dividends and buybacks

INVALLY
Dividends and buybacks
Dividend yield–0.4%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield0.3%0.3%
Shareholder yield0.3%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: INVA or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Innoviva or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.32T) is about 967.8 times Innoviva ($1.4B), at today's prices.

How did INVA and LLY stock do over the last 10 years?

Since November 18, 2016, INVA's price moved +68.3% and LLY's +1,719.8%. With dividends: INVA +68.3% (+5.3% a year), LLY +2,016.8% (+35.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, INVA or LLY?

The dividend yield at today's price is none for Innoviva and 0.45% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of INVA and LLY?

At today's price, the P/E is 7.0 for INVA and 47.7 for LLY. The median of the last five years was 6.1 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, Innoviva or Eli Lilly and Company?

Over the last twelve months, the net margin was 44.1% for Innoviva and 31.9% for Eli Lilly and Company, and the operating margin 38.8% and –. Revenue was $438M and $86.5B.

Which is the better investment, Innoviva or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.